At i+Med, we are thrilled to announce a significant milestone in our journey towards providing innovative healthcare solutions. Our flagship products, Profilm Herpes and Profilm Oral Ulcers, have achieved Medical Device Regulation (MDR) certification. This...
We are thrilled to share that i+Med has successfully obtained the MDR certification for their groundbreaking product, Daydrop! 🎉 The Medical Device Regulation (MDR) certification is a significant milestone, reflecting i+Med’s unwavering commitment to safety,...
i+Med presents BtHLINE and BtHCROSS, its new Hyaluronic Acid facial injectables, at the March clinic in Marbella by the prestigious Dr. Rafael Fernández “Diamond Jaw”. The meeting was attended by aesthetic medicine doctors from the USA, Holland, Uruguay...
On Monday, 6 February 2023, coinciding with its 10th anniversary, i+Med laid the first stone of its new headquarters, Gure Etxea, the first International Biomedical Institute for Intelligent Nanohydrogels (IBIN). A world reference in terms of scientific research. It...
The investment will initially generate 60 new highly qualified jobs. The Institute will also be its new headquarters and will be located in the Alava Technologic Park. The project consolidates i+Med in the field of ‘personalised medicine’ based on...
From @i+Med we present BuddyDrops®, a novel long-lasting moisturising and lubricating eye drop that helps to maintain moisture and eye hygiene in pets. BuddyDrops® are the only drops on the market with a combination of ectoine, hyaluronic acid and carmellose together...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkNo
You can revoke your consent any time using the Revoke consent button.Revoke consent